Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-222869
Filing Date
2024-09-20
Accepted
2024-09-20 16:01:55
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B5 d889666d424b5.htm 424B5 1184839
2 EX-FILING FEES d889666dexfilingfees.htm   iXBRL EX-FILING FEES 31014
3 GRAPHIC g889666g25m25.jpg GRAPHIC 77002
4 GRAPHIC g889666g36d40.jpg GRAPHIC 34313
5 GRAPHIC g889666g66m01.jpg GRAPHIC 210056
  Complete submission text file 0001193125-24-222869.txt   1792962

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT d889666dexfilingfees_htm.xml XML 7543
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-282196 | Film No.: 241313340
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)